• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Commentary: Surgical risk assessment in 2020: Is a handshake and a walking test really the best we've got?

作者信息

Chan Ernest G, Ekeke Chigozirim N, Luketich James D

机构信息

Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, Pittsburgh, Pa.

Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, Pittsburgh, Pa.

出版信息

J Thorac Cardiovasc Surg. 2021 Mar;161(3):834-835. doi: 10.1016/j.jtcvs.2020.11.040. Epub 2020 Nov 20.

DOI:10.1016/j.jtcvs.2020.11.040
PMID:33422318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8680218/
Abstract
摘要

相似文献

1
Commentary: Surgical risk assessment in 2020: Is a handshake and a walking test really the best we've got?评论：2020年的手术风险评估：握手和步行测试真的是我们所能采用的最佳方法吗？
J Thorac Cardiovasc Surg. 2021 Mar;161(3):834-835. doi: 10.1016/j.jtcvs.2020.11.040. Epub 2020 Nov 20.
2
Commentary: Whether it's the best of times or the worst of times, it's the only time we've got.评论：无论是最好的时代还是最坏的时代，都是我们仅有的时代。
JTCVS Open. 2021 Mar;5:26-27. doi: 10.1016/j.xjon.2020.12.007. Epub 2020 Dec 29.
3
Dissemination of evidence-based practices: how far we've come, and how much further we've got to go.循证实践的传播：我们已取得的进展，以及仍需走的路。
Addiction. 2012 Jun;107(6):1031-3. doi: 10.1111/j.1360-0443.2011.03755.x. Epub 2012 Feb 11.
4
Acute kidney injury: we've got the diagnosis, now what?
Can J Anaesth. 2012 Oct;59(10):919-27. doi: 10.1007/s12630-012-9767-8. Epub 2012 Aug 16.
5
You've got questions; we've got answers--maybe.你有问题；我们可能有答案。
JEMS. 2006 Jun;31(6):34, 37. doi: 10.1016/s0197-2510(06)70423-5.
6
We've got to stop meeting like this!
J Am Coll Cardiol. 1997 Feb;29(2):455-6. doi: 10.1016/s0735-1097(96)00419-6.
7
We've got rhythm.
Newsweek. 2004 Oct 11;144(15):46.
8
We've Got the Panels.我们有专门小组了。
Can Med Assoc J. 1967 Nov 4;97(19):1172-3.
9
Bladder cancer: Validating what we've got.膀胱癌：验证我们所拥有的。
Can Urol Assoc J. 2013 Jan-Feb;7(1-2):33-4. doi: 10.5489/cuaj.236.
10
We've all got rhythm.
Trends Cogn Sci. 2001 Aug 1;5(8):331.

引用本文的文献

1
Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted.白细胞介素-6拮抗剂治疗新冠病毒疾病患者的疗效：有必要开展进一步的随机对照试验。
Hum Cell. 2021 Nov;34(6):1943-1944. doi: 10.1007/s13577-021-00616-x. Epub 2021 Sep 15.

本文引用的文献

1
Looking beyond the eyeball test: A novel vitality index to predict recovery after esophagectomy.超越眼球测试：一种新的活力指数预测食管癌手术后的恢复情况。
J Thorac Cardiovasc Surg. 2021 Mar;161(3):822-832.e6. doi: 10.1016/j.jtcvs.2020.10.122. Epub 2020 Nov 13.
2
The Society of Thoracic Surgeons General Thoracic Surgery Database 2018 Update on Outcomes and Quality.《胸外科医师学会胸外科数据库 2018 年关于结果和质量的更新》。
Ann Thorac Surg. 2018 May;105(5):1304-1307. doi: 10.1016/j.athoracsur.2018.02.006. Epub 2018 Mar 5.
3
The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer.PER（术前食管切除术风险）评分：一种预测手术治疗食管癌患者短期和长期预后的简单风险评分。
Medicine (Baltimore). 2016 Feb;95(7):e2724. doi: 10.1097/MD.0000000000002724.
4
Readmission predicts 90-day mortality after esophagectomy: Analysis of Surveillance, Epidemiology, and End Results Registry linked to Medicare outcomes.再入院可预测食管癌切除术后90天死亡率：与医疗保险结果相关的监测、流行病学和最终结果登记分析。
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1254-60. doi: 10.1016/j.jtcvs.2015.08.071. Epub 2015 Aug 28.
5
The Surgical Apgar Score in esophagectomy.手术 Apgar 评分在食管癌根治术中的应用。
J Thorac Cardiovasc Surg. 2015 Oct;150(4):806-12. doi: 10.1016/j.jtcvs.2015.07.017. Epub 2015 Jul 10.
6
Validation of a new approach for mortality risk assessment in oesophagectomy for cancer based on age- and gender-corrected body mass index.基于年龄和性别校正体重指数的食管癌切除术死亡风险评估新方法的验证
Eur J Cardiothorac Surg. 2015 Oct;48(4):600-7. doi: 10.1093/ejcts/ezu503. Epub 2015 Jan 5.
7
Assessment of morbidity and mortality after esophagectomy using a modified frailty index.使用改良衰弱指数评估食管癌手术后的发病率和死亡率。
Ann Thorac Surg. 2013 Oct;96(4):1240-1245. doi: 10.1016/j.athoracsur.2013.05.051. Epub 2013 Jul 31.
8
Outcomes after minimally invasive esophagectomy: review of over 1000 patients.微创食管切除术的结果：超过 1000 例患者的回顾。
Ann Surg. 2012 Jul;256(1):95-103. doi: 10.1097/SLA.0b013e3182590603.